New treatment options expand management of relapsed or refractory disease.
David Bond, MD
Advertisement
Articles by David Bond, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
2
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
3
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
4
MDA 2026 to Bring Keynote Insights and Evolving Neuromuscular Care
5
